These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18379976)

  • 1. A novel catheter system for totally implantable intravenous drug therapy: assessment of catheter function and patency with trepostinil therapy.
    Morris M; Phares K; Zaccardelli D; Ujhelyi MR
    J Vasc Access; 2008; 9(1):20-7. PubMed ID: 18379976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.
    Bourge RC; Waxman AB; Gomberg-Maitland M; Shapiro SM; Tarver JH; Zwicke DL; Feldman JP; Chakinala MM; Frantz RP; Torres F; Cerkvenik J; Morris M; Thalin M; Peterson L; Rubin LJ
    Chest; 2016 Jul; 150(1):27-34. PubMed ID: 27396777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure.
    Waxman AB; McElderry HT; Gomberg-Maitland M; Burke MC; Ross EL; Bersohn MM; Pangarkar SS; Tarver JH; Zwicke DL; Feldman JP; Chakinala MM; Frantz RP; Thompson GB; Torres F; Rauck RL; Clagg K; Durst L; Li P; Morris M; Southall KL; Peterson L; Bourge RC
    Chest; 2017 Dec; 152(6):1128-1134. PubMed ID: 28583617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.
    Ivy DD; Calderbank M; Wagner BD; Dolan S; Nyquist AC; Wade M; Nickels WM; Doran AK
    Infect Control Hosp Epidemiol; 2009 Sep; 30(9):823-9. PubMed ID: 19637961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transition from intravenous to subcutaneous prostacyclin in pulmonary hypertension].
    Escribano Subías P; Cea-Calvo L; Tello de Menesses R; Gómez Sánchez MA; Delgado Jiménez JF; Sáenz de la Calzada C
    Rev Esp Cardiol; 2003 Aug; 56(8):818-21. PubMed ID: 12892628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "bouncing" catheter.
    Malaczynska-Rajpold K; Kurzyna M; Koteja A; Torbicki A; Mularek-Kubzdela T
    Cardiol J; 2016; 23(5):552-553. PubMed ID: 27723062
    [No Abstract]   [Full Text] [Related]  

  • 7. An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil.
    Kurzyna M; Małaczyńska-Rajpold K; Koteja A; Pawlak A; Chrzanowski Ł; Furdal M; Gąsior Z; Jacheć W; Sobkowicz B; Norwa J; Mularek-Kubzdela T; Torbicki A
    BMC Pulm Med; 2017 Dec; 17(1):162. PubMed ID: 29195500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(8):170-2. PubMed ID: 17332729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension.
    Ewert R; Richter MJ; Steringer-Mascherbauer R; Grünig E; Lange TJ; Opitz CF; Warnke C; Ghofrani HA
    Clin Res Cardiol; 2017 Oct; 106(10):776-783. PubMed ID: 28429083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treprostinil for the treatment of pulmonary hypertension.
    Skoro-Sajer N; Lang I
    Expert Opin Pharmacother; 2008 Jun; 9(8):1415-20. PubMed ID: 18473715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo canine study to assess granulomatous responses in the MedStream Programmable Infusion System (TM) and the SynchroMed II Infusion System®.
    Michael A; Buffen E; Rauck R; Anderson W; McGirt M; Mendenhall HV
    Pain Med; 2012 Feb; 13(2):175-84. PubMed ID: 22239738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension.
    Richter MJ; Ewert R; Warnke C; Gall H; Classen S; Grimminger F; Mayer E; Seeger W; Ghofrani HA
    Clin Res Cardiol; 2017 Mar; 106(3):174-182. PubMed ID: 27670656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treprostinil for pulmonary hypertension.
    Vachiéry JL; Naeije R
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension.
    Rich JD; Glassner C; Wade M; Coslet S; Arneson C; Doran A; Gomberg-Maitland M
    Chest; 2012 Jan; 141(1):36-42. PubMed ID: 21659437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous catheter infections in pulmonary arterial hypertension.
    Gaine S; Gomberg-Maitland M
    Int J Clin Pract Suppl; 2008 Jul; (160):3-4. PubMed ID: 18638169
    [No Abstract]   [Full Text] [Related]  

  • 16. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.
    Gomberg-Maitland M; Tapson VF; Benza RL; McLaughlin VV; Krichman A; Widlitz AC; Barst RJ
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1586-9. PubMed ID: 16151039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent effects of aerosol compared with intravenous treprostinil on the pulmonary circulation.
    Sandifer BL; Brigham KL; Lawrence EC; Mottola D; Cuppels C; Parker RE
    J Appl Physiol (1985); 2005 Dec; 99(6):2363-8. PubMed ID: 16141385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treprostinil for the treatment of pulmonary arterial hypertension.
    Torres F; Rubin LJ
    Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
    LeVarge BL; Channick RN
    Expert Rev Respir Med; 2012 Jun; 6(3):255-65. PubMed ID: 22788940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil.
    Ivy DD; Claussen L; Doran A
    Am J Cardiol; 2007 Mar; 99(5):696-8. PubMed ID: 17317374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.